HU210689B - Process for producing tigogenin-beta-cellobioside - Google Patents

Process for producing tigogenin-beta-cellobioside Download PDF

Info

Publication number
HU210689B
HU210689B HU903816A HU381690A HU210689B HU 210689 B HU210689 B HU 210689B HU 903816 A HU903816 A HU 903816A HU 381690 A HU381690 A HU 381690A HU 210689 B HU210689 B HU 210689B
Authority
HU
Hungary
Prior art keywords
tigogenin
formula
beta
cellobioside
methylene chloride
Prior art date
Application number
HU903816A
Other languages
English (en)
Hungarian (hu)
Other versions
HUT54708A (en
HU903816D0 (en
Inventor
Frank John Urban
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to HU271590A priority Critical patent/HUT61571A/hu
Publication of HU903816D0 publication Critical patent/HU903816D0/hu
Publication of HUT54708A publication Critical patent/HUT54708A/hu
Priority to HU9202715A priority patent/HU211082B/hu
Publication of HU210689B publication Critical patent/HU210689B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Catalysts (AREA)
HU903816A 1989-06-13 1990-06-12 Process for producing tigogenin-beta-cellobioside HU210689B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU271590A HUT61571A (en) 1989-06-13 1990-06-12 Process for producing tigogenin-orthoester derivatives
HU9202715A HU211082B (hu) 1989-06-13 1992-08-19 Eljárás tigogenin-ortoészter-származékok előállítására

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/365,588 US5010185A (en) 1989-06-13 1989-06-13 Processes for tigogenin beta-cellobioside

Publications (3)

Publication Number Publication Date
HU903816D0 HU903816D0 (en) 1990-11-28
HUT54708A HUT54708A (en) 1991-03-28
HU210689B true HU210689B (en) 1995-06-28

Family

ID=23439483

Family Applications (1)

Application Number Title Priority Date Filing Date
HU903816A HU210689B (en) 1989-06-13 1990-06-12 Process for producing tigogenin-beta-cellobioside

Country Status (23)

Country Link
US (1) US5010185A (cs)
EP (1) EP0403150B1 (cs)
JP (1) JPH0637514B2 (cs)
KR (1) KR920002146B1 (cs)
AT (1) ATE114155T1 (cs)
AU (1) AU619986B2 (cs)
CA (1) CA2018722A1 (cs)
CZ (1) CZ279909B6 (cs)
DD (1) DD295164A5 (cs)
DE (1) DE69014152T2 (cs)
DK (1) DK0403150T3 (cs)
ES (1) ES2063269T3 (cs)
FI (1) FI902937A7 (cs)
HU (1) HU210689B (cs)
IE (1) IE64057B1 (cs)
IL (1) IL94650A (cs)
NO (1) NO902600L (cs)
NZ (1) NZ234028A (cs)
PL (3) PL163259B1 (cs)
PT (1) PT94337A (cs)
RU (1) RU2042688C1 (cs)
YU (1) YU47515B (cs)
ZA (1) ZA904527B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294703A (en) * 1992-05-01 1994-03-15 Eastman Kodak Company Process for preparing α-D-cellobiose octaacetate
AU4044293A (en) * 1992-06-26 1994-01-24 Pfizer Inc. Process for steroidal peracyl glycosides
AU4226593A (en) * 1992-06-26 1994-01-24 Pfizer Inc. Steroidal glycosides for treating hypercholesterolemia
FI946081L (fi) * 1992-06-26 1994-12-23 Pfizer Steroidaalinen beta-0-sellobiosidihepta-alkanoaattimenetelmä
US5530107A (en) * 1992-10-15 1996-06-25 Pfizer Inc. Method for making steroidal peracyl glycosides
CZ280195A3 (en) * 1993-04-28 1996-02-14 Pfizer Crystalline spirostanyl glycoside, monohydrate thereof, pharmaceutical composition based thereon and process for preparing crystalline steroidal glycoside
US5502038A (en) * 1993-06-21 1996-03-26 Medical Research Foundation Of Oregon Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption
ES2074006B1 (es) * 1993-07-05 1996-03-16 Pfizer Glicosidos esteroidales para tratar hipercolesterolemia.
GB9806513D0 (en) * 1998-03-26 1998-05-27 Phytopharm Ltd Membrane-bound receptors
JP4589869B2 (ja) * 2002-07-12 2010-12-01 塩野義製薬株式会社 酸触媒として機能するゼオライト類似体の簡易な製造法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602005A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis
US4602003A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia

Also Published As

Publication number Publication date
KR910000779A (ko) 1991-01-30
NO902600L (no) 1990-12-14
KR920002146B1 (ko) 1992-03-12
JPH0637514B2 (ja) 1994-05-18
CZ289090A3 (en) 1995-04-12
ZA904527B (en) 1992-01-29
FI902937A0 (fi) 1990-06-12
IL94650A0 (en) 1991-04-15
DD295164A5 (de) 1991-10-24
JPH0331297A (ja) 1991-02-12
IE64057B1 (en) 1995-07-12
DK0403150T3 (da) 1995-01-16
HUT54708A (en) 1991-03-28
PL163258B1 (pl) 1994-02-28
PL289135A1 (en) 1992-02-24
YU47515B (sh) 1995-10-03
FI902937A7 (fi) 1990-12-14
CA2018722A1 (en) 1990-12-13
HU903816D0 (en) 1990-11-28
EP0403150A2 (en) 1990-12-19
ES2063269T3 (es) 1995-01-01
IL94650A (en) 1994-11-11
DE69014152T2 (de) 1995-03-23
CZ279909B6 (cs) 1995-08-16
PL163219B1 (pl) 1994-02-28
IE902101L (en) 1990-12-13
DE69014152D1 (de) 1994-12-22
RU2042688C1 (ru) 1995-08-27
PT94337A (pt) 1991-02-08
NO902600D0 (no) 1990-06-12
AU619986B2 (en) 1992-02-06
ATE114155T1 (de) 1994-12-15
YU114590A (en) 1991-10-31
PL163259B1 (pl) 1994-02-28
PL289136A1 (en) 1992-02-24
NZ234028A (en) 1991-10-25
AU5707990A (en) 1991-08-01
EP0403150B1 (en) 1994-11-17
US5010185A (en) 1991-04-23
EP0403150A3 (en) 1992-06-17
PL285593A1 (en) 1991-07-01
IE902101A1 (en) 1991-01-02

Similar Documents

Publication Publication Date Title
US5621087A (en) Process for making morphine-6-glucuronide or substituted morphine-6-glucuronide
US4425273A (en) Process for production of chenodeoxycholic acid
JP2546659B2 (ja) ポドフイロトキシン型化合物の製造方法
HU210689B (en) Process for producing tigogenin-beta-cellobioside
KR970002642B1 (ko) 안드로스탄 17-카복실산 에스테르, 이의 제조방법, 및 이를 함유하는 약제
JP3231765B2 (ja) デメチルエピポドフィロトキシンの製造方法
US4758383A (en) Ergosta-1,5,7,22-tetraen-3β-ol and its use as an intermediate for 1α-hydroxy vitamin D2
AU775831B2 (en) Process for preparing 17alpha-acetoxy-11beta-(4-N,N-(dimethylamino)phenyl)-21- methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates
EP0080381B1 (en) Homobrassinolide, and its production and use
HU207867B (en) Process for producing benzopiranon-beta-d-thioxylozide derivatives and pharmaceutical compositions containing them
US4490296A (en) Compositions and method
RU2009146C1 (ru) Способ получения производных 19-норпрогестерона
US4565656A (en) Preparation of 17β-hydroxyacetyl-17α-ol-steroids
CS212218B2 (en) Method of producing the new steroids of the pregnane series substituted in the position 17
HU197755B (en) Process for producing 3-alkoxy-18-methyl-3,5-estradien-17-one or 3-alkoxy-18-methyl-3,5,15-estratrien-17-one derivatives
US4843157A (en) 13alpha-alkylgonan-delta 9(11)-5,10-epoxides
HU211082B (hu) Eljárás tigogenin-ortoészter-származékok előállítására
US4855417A (en) Anomeric deacetylation
Werschkun et al. Sigmatropic rearrangement of uronic acid derived saccharide allyl ketene acetals. A study of stereochemistry and structural limitations
JPS60166680A (ja) スワインソニンの製造方法
JP2753353B2 (ja) シアロシルコレステロールのアナログ体及びその製造方法
EP0582153B1 (en) Method of preparing 4-deoxy-D-mannose
JP2714392B2 (ja) ステロイド誘導体の製造法
JPH0912594A (ja) ステロイド骨格を有する化合物類及びそれらによるゴキブリ拘束物質の製造方法ならびにステロイド骨格を有する新規化合物
Allevi et al. Synthesis of 7α, 12α-dihydroxy-3α-[2-(β-d-glucopyranosyl) acetyl]-5β-cholan-24-oic acid

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee